In the United States,<unk>  (Eloctate) is indicated for adults and children with Hemophilia A for (1) on-demand treatment and control of bleeding episodes, (2) perioperative management, and (3) routine prophylaxis to prevent or reduce the frequency of bleeding episodes. In the European Union,<unk>  (Elocta) is indicated for treatment and prophylaxis of bleeding in people with haemophilia A.
Efmoroctocog alfa
Vonicog alfa
Drotrecogin alfa
Moroctocog alfa
Etelcalcetide
Susoctocog alfa
Damoctocog alfa pegol
Difelikefalin